[et_pb_section fb_built=”1″ admin_label=”!!! PLEASE DO NOT EDIT !!!” _builder_version=”4.16″ global_colors_info=”{}”][et_pb_row admin_label=”!!! PLEASE DO NOT EDIT !!!” _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text admin_label=”TO BE EDITED – TEXT – Click on the WHEEL icon to open the text-area where you can type your text. Add a paragraph to introduce the Document” _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
Over the past three decades, the world has made significant progress in improving population health, particularly in low- and lower-middle-income countries. Reductions in infant mortality and the disease burden among young children reflect both socioeconomic development and advances in health interventions. While domestic investments have played the leading role in financing these improvements, Development Assistance for Health<\/a> (DAH) has provided critical support\u2014especially in low-income countries\u2014to implement and sustain essential health programs and systems. However, as domestic health financing grows and donor priorities evolve, the role and relevance of DAH are undergoing important shifts.<\/p>\n